CLEVELAND – September 21, 2015
BioMotiv has entered into a strategic partnership with Biogen. This discovery collaboration will leverage the strengths of both organizations to identify pioneering neuroscience discoveries and advance them into medicines. The partnership includes a Biogen investment of $15 million in BioMotiv.

Click here to read more